Age

Any age

Sex

FEMALE

Healthy volunteers

Not accepted

Histologically confirmed advanced breast cancer, including inoperable locally advanced breast cancer and recurrent/metastatic breast cancer.
No restriction on ER, PR and HER2 status.
Prior receipt of systemic anti-tumor therapy for advanced breast cancer.
Complete response (CR) assessed by PET-CT.
Patients voluntarily participate in this project and sign the informed consent form.

Pregnant or lactating women.
Presence of concomitant diseases that, in the investigator's judgment, may seriously endanger patient safety or interfere with study completion.
Patients with brain metastases.

Exploring Curative Model for Advanced Breast Cancer: a Single-center, Prospective Phase II Clinical Study